Oxidative stress associated with rapid weight reduction decreases circulating adiponectin concentrations. 2010

Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

The effect of stress associated with acute weight reduction on adipocytokine production is incompletely understood. In the present study, we have investigated the changes in circulating adipocytokine concentrations and urinary concentrations of stress markers in male collegiate wrestlers during acute weight reduction for a competition. Twenty healthy Japanese male wrestlers (18-22 years of age) who participated in the national collegiate wrestling tournament were studied. Body weight, body fat amount, serum testosterone, serum leptin, serum adiponectin, urinary 8-hydroxy-2'- deoxyguanosine (8-OHdG) and urinary biopyrrins were analyzed during acute weight reduction for the competition. Body weight, body fat amount and the serum concentrations of testosterone, leptin and adiponectin significantly decreased on the day of weigh-in compared with the levels 12 days before weigh-in. In contrast, urinary concentrations of 8-OHdG and biopyrrins significantly increased on the day of weigh-in compared with the concentrations 12 days before weigh-in. A positive correlation was observed between the serum concentrations of adiponectin and testosterone, and a negative correlation was observed between the concentrations of serum adiponectin and urinary biopyrrins. The present results suggest that rapid weight reduction increases the urinary concentrations of stress markers, which is associated with a decrease in serum concentrations of adiponectin.

UI MeSH Term Description Entries
D008297 Male Males
D003849 Deoxyguanosine A nucleoside consisting of the base guanine and the sugar deoxyribose.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000080242 8-Hydroxy-2'-Deoxyguanosine Common oxidized form of deoxyguanosine in which C-8 position of guanine base has a carbonyl group. 2'-Deoxy-7,8-Dihydro-8-Oxoguanosine,2'-Deoxy-8-Hydroxyguanosine,2'-Deoxy-8-Oxo-7,8-Dihydroguanosine,2'-Deoxy-8-Oxoguanosine,7,8-Dihydro-8-Oxo-2'-Deoxyguanosine,7-Hydro-8-Oxodeoxyguanosine,8-Hydroxydeoxyguanosine,8-Oxo-2'-Deoxyguanosine,8-Oxo-7,8-Dihydro-2'-Deoxyguanosine,8-Oxo-7,8-Dihydrodeoxyguanosine,8-Oxo-7-Hydrodeoxyguanosine,8-Oxo-Deoxyguanosine,8OHdG,8-OH-dG,8-oxo-dG,8-oxo-dGuo,8-oxodG,8-oxodGuo,2' Deoxy 7,8 Dihydro 8 Oxoguanosine,2' Deoxy 8 Hydroxyguanosine,2' Deoxy 8 Oxo 7,8 Dihydroguanosine,2' Deoxy 8 Oxoguanosine,7 Hydro 8 Oxodeoxyguanosine,7,8 Dihydro 8 Oxo 2' Deoxyguanosine,8 Hydroxy 2' Deoxyguanosine,8 Hydroxydeoxyguanosine,8 Oxo 2' Deoxyguanosine,8 Oxo 7 Hydrodeoxyguanosine,8 Oxo 7,8 Dihydro 2' Deoxyguanosine,8 Oxo 7,8 Dihydrodeoxyguanosine,8 Oxo Deoxyguanosine
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone
D014952 Wrestling A sport consisting of hand-to-hand combat between two unarmed contestants seeking to pin or press each other's shoulders to the ground. Wrestlings
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
September 2006, Diabetes research and clinical practice,
Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
April 2008, American journal of physiology. Endocrinology and metabolism,
Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
January 2016, PloS one,
Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
January 2012, Disease markers,
Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
July 2013, Obesity (Silver Spring, Md.),
Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
October 2006, Heart (British Cardiac Society),
Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
July 2023, International journal of obesity (2005),
Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
September 2018, The Journal of nutrition,
Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
September 1964, The Journal of sports medicine and physical fitness,
Yoshimaro Yanagawa, and Tadashi Morimura, and Katsuhiko Tsunekawa, and Koji Seki, and Takayuki Ogiwara, and Nobuo Kotajima, and Tetsuo Machida, and Shingo Matsumoto, and Takumi Adachi, and Masami Murakami
August 2019, Endocrine connections,
Copied contents to your clipboard!